Repligen (RGEN) Invested Capital (2010 - 2026)

Repligen (RGEN) has 17 years of Invested Capital data on file, last reported at $2.7 billion in Q1 2026.

• Quarterly Invested Capital rose 31.33% year-over-year to $2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 billion (up 31.33% YoY) and the FY2025 annual result came in at $2.6 billion, up 6.01% from the prior year.
• Invested Capital held at $2.7 billion in Q1 2026 per RGEN's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Invested Capital topped out at $2.7 billion in Q1 2026 and bottomed at $1.8 billion in Q1 2022.
• The 5-year median for Invested Capital is $2.1 billion (2024), against an average of $2.2 billion.
• The widest annual swing landed in 2023, when Invested Capital jumped 33.26%; it then slipped 21.29% in 2025.
• Tracing RGEN's Invested Capital over 5 years: stood at $1.9 billion in 2022, then soared by 33.26% to $2.6 billion in 2023, then declined by 2.6% to $2.5 billion in 2024, then grew by 6.01% to $2.6 billion in 2025, then advanced by 0.14% to $2.7 billion in 2026.
• Per Business Quant, the three latest RGEN Invested Capital figures stand at $2.7 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025).

Peer Comparison